Pfizer Inc. Still Wants AstraZeneca PLC After $98.7 Billion Bid Rejected

Published: Apr 29, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Pfizer Inc. (PFE:US) proposed buying AstraZeneca Plc (AZN) for about 58.8 billion pounds ($98.7 billion) in what would rank as the biggest-ever takeover of a U.K. company and said it continues to be interested in a deal even after being spurned. Pfizer offered 46.61 pounds a share in cash and stock for London-based AstraZeneca last January, and AstraZeneca declined to pursue negotiations, New York-based company Pfizer said in a statement today. The proposal is about 14 percent above the April 25 close for AstraZeneca.

Help employers find you! Check out all the jobs and post your resume.

Back to news